German drug regulator considering export ban on Ozempic
The head of Germany’s drug regulator BfArM is considering an export ban on Novo Nordisk’s (NOVOb.CO) diabetes drug Ozempic, which is in high demand for its weight-loss ...
Stay up to date with the latest health news, wellness advice, medical research, and public health updates in Cyprus and around the world.